Landmark, third-party research strengthens evidence of long-term impact beyond a single Girls on the Run season. CHARLOTTE, NC, UNITED STATES, March 25, 2026 ...
In 2021, Arizona softball had nine run-rule victories in 10 games. The one that kept them from going 10 straight was an extra-inning affair against Oregon State. That kept the program record for ...
March 12 (UPI) --The recent, new delay in NASA's moon landing program represents the latest in a string of technical, budgetary, workforce and public perception challenges that plague the space agency ...
Luke Lindberg, USDA's undersecretary for trade and foreign agricultural affairs. (USDA photo) Luke Lindberg, USDA’s undersecretary for trade and foreign agricultural affairs, is the leading contender ...
CHARLESTON — A nonprofit run by City Councilman Aaron Polkey, who was sworn in last month, is set to receive nearly $240,000 from the city for a homeless program. Polkey, president and CEO of Palmetto ...
Running is one of the best investments you can make in yourself as you get older—and it’s never too late to start (or start again). Our new program, How to Run Strong at 50+, is designed to help you ...
When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...
Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...
Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...
TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...
Remote-first AI coding startup Kilo doesn't think software developers should have to pledge their undying allegiance to any one development environment — and certainly not any one model or harness.
Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results